Edgewise Therapeutics
EWTX
EWTX
200 hedge funds and large institutions have $2.64B invested in Edgewise Therapeutics in 2024 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 71 increasing their positions, 63 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% more funds holding in top 10
Funds holding in top 10: 8 → 9 (+1)
2% less capital invested
Capital invested by funds: $2.7B → $2.64B (-$62.2M)
3.51% less ownership
Funds ownership: 108.06% → 104.55% (-3.5%)
Holders
200
Holding in Top 10
9
Calls
$23.3M
Puts
$9.81M
Top Buyers
| 1 | +$45.5M | |
| 2 | +$20.8M | |
| 3 | +$14.7M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$11.4M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
+$9.98M |
Top Sellers
| 1 | -$56.4M | |
| 2 | -$41.7M | |
| 3 | -$33.4M | |
| 4 |
VA
VR Adviser
New York
|
-$26.7M |
| 5 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$14.7M |